Zhejiang Hisun Pharmaceutical (600267.SH) releases a forecasted profit, estimating a net profit of 570-630 million yuan in 2024, turning losses into profits.
Guangzhou Pharmaceuticals Corporation (stock code: 600267.SH) announced that the company is expected to achieve attributable net profit to shareholders of the listed company for the year 2024...
Zhejiang Hisun Pharmaceutical (600267.SH) announced that the company expects to achieve a net profit attributable to shareholders of the listed company of 570 million to 630 million yuan in 2024, compared to a loss in the same period last year.
Related Articles
Fujian Longxi Bearing(Group) Corp.,(600592.SH) received a correction order from the Fujian Securities Regulatory Bureau.
Chengdu Yunda Technology (300440.SZ): Sichuan Securities Regulatory Bureau takes enforcement actions against the company to make corrections.
TIANJIN PORT DEV (03382) plans to purchase a gantry crane for 21.49 million yuan
Fujian Longxi Bearing(Group) Corp.,(600592.SH) received a correction order from the Fujian Securities Regulatory Bureau.
Chengdu Yunda Technology (300440.SZ): Sichuan Securities Regulatory Bureau takes enforcement actions against the company to make corrections.
TIANJIN PORT DEV (03382) plans to purchase a gantry crane for 21.49 million yuan
